Transition state analog inhibitors and enzyme catalysis.
D000447:Aldehydes; D000619:Aminohydrolases / Q000037:antagonists & inhibitors; D000900:Anti-Bacterial Agents; D001593:Benzyl Compounds; D001897:Boronic Acids; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors; D002384:Catalysis; D002553:Cerebroside-Sulfatase / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors; D006026:Glycoside Hydrolases / Q000037:antagonists & inhibitors; D006867:Hydrolases / Q000037:antagonists & inhibitors; D007535:Isomerases / Q000037:antagonists & inhibitors; D007700:Kinetics; D008025:Ligases / Q000037:antagonists & inhibitors; D008190:Lyases / Q000037:antagonists & inhibitors; D008727:Methotrexate; D008968:Molecular Conformation; D010070:Oxalates; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011485:Protein Binding; D012260:Ribonucleases / Q000037:antagonists & inhibitors; D013780:Tetroses; D014166:Transferases / Q000037:antagonists & inhibitors
D000447:Aldehydes; D000900:Anti-Bacterial Agents; D001593:Benzyl Compounds; D001897:Boronic Acids; D004791:Enzyme Inhibitors; D010070:Oxalates; D013780:Tetroses; D010088:Oxidoreductases; D014166:Transferases; D006867:Hydrolases; D012260:Ribonucleases; D002553:Cerebroside-Sulfatase; D006026:Glycoside Hydrolases; D002268:Carboxypeptidases; D000619:Aminohydrolases; D008190:Lyases; D007535:Isomerases; D008025:Ligases; D008727:Methotrexate